Encouraging exercise
After all that the industry went through in the last few months on matters of pricing, excise or VAT proposals, the industry expected the budget to set right some of the anomalies.

IPRs and business strategy options
Parikshit Bansal and Anand Sharma examine the strategy of two leading pharma companies as case studies on business strategy options in a changed global scenario where IPRs are dictating survival of the pharma industry Parikshit Bansal and Anand Sharma